【ChiCTR2000029649】Recurrence and satisfaction with sutured surgical treatment of an ingrown toenail with nail and matrix preservation
ChiCTR2000029649
结束
/
/
/
2020-02-09
/
/
ingrown toenail
Recurrence and satisfaction with sutured surgical treatment of an ingrown toenail with nail and matrix preservation
Recurrence and satisfaction with sutured surgical treatment of an ingrown toenail with nail and matrix preservation
61-545
Techniques with the preservation of the nail and matrix are not often used. We have found that the nail plate itself is a good point for skin plasty. We were interested in whether a satisfactory result could be obtained without removal or partial resection of the nail plate, i.e. with only soft tissue resection and skin plasty. Our goal was to evaluate the results of ingrown nail corrections in patients who underwent our surgical approach in terms of healing time, pain relief, relapse and scarring.
单臂
回顾性研究
no
/
no sponsor
/
40
/
2017-07-10
2019-08-12
/
Participants in the study were included if they were children, adolescents or adults who decided to undergo our procedure with preservation of the nail and matrix for one or more ingrown toenails.；
请登录查看Individuals were excluded if they could not understand Polish or had significant medical comorbidities.；
请登录查看Mikolaj Dabrowski
61-545
Mikolaj Dabrowski的其他临床试验
波兰波茲南医科大学脊柱矫形与生物力学系的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-28
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10